Evidence before treatment.
Testosterone replacement therapy is considered when compatible symptoms and clinical findings align with consistently low testosterone, confirmed through repeat morning fasting testing. A low result alone is not enough.
TESTOSTERONE EVALUATION & TREATMENTTestosterone care.
Testosterone care.
Clinical judgment first.
Testosterone evaluation alongside metabolic health, sleep and medical history. Confirmed findings come first. Treatment and monitoring follow when clinically indicated.
Clinical judgment first
More than a laboratory result.
Context changes the plan.
Weight, sleep disorders, medications and other health conditions can influence testosterone findings. Addressing reversible contributors may be the right first step; not every evaluation leads to TRT.
Monitoring is part of care.
Treatment requires ongoing review of response, testosterone levels, blood counts and adverse effects, with prostate assessment when appropriate. Fertility goals and individual risks belong in the decision from the start.
Connected evaluation. Separate treatment decisions. TRT is not an automatic companion to weight-management or peptide care.
Treatment formats / clinical selectionDifferent formats.
Different formats.
One clinical standard.
Delivery format follows evaluation—not the other way around. Explore how the clinical conversations differ.
01 / Injectable format
Discuss at a consultation
A format. Not a shortcut.
Injectable testosterone is one delivery option considered after confirmed deficiency and an individual prescribing evaluation.
- Assessment
- Clinical history and repeat morning testosterone testing.
- Follow-through
- Provider visits, appropriate labs and dosing review.
- Format & costs
- The prescribed formulation and applicable fees are confirmed separately.
The provider confirms the exact formulation and approval status; compounded medications are not FDA-approved. TRT can suppress sperm production. Product-specific risks, monitoring and fertility considerations require review.
Clinical context
The label identifies a treatment format, not a particular dispensed formulation, strength or approval status. Packaging varies. FDA-approved and compounded formulations are distinct; compounded medications are not FDA-approved. Booking does not guarantee a prescription.
02 / Topical format
Discuss at a consultation
Application matters.
Creams and gels are another testosterone-care conversation. Suitability and precautions depend on the exact prescribed product.
- Selection
- Product, medical history and practical considerations.
- Precautions
- Product-specific application and transfer precautions.
- Review
- Follow-up testing and clinical monitoring remain part of care.
FDA-approved products and compounded creams are distinct; compounded creams are not FDA-approved. Some topical testosterone products can transfer through contact. Product-specific precautions and fertility risks require review.
Clinical context
The pump is a generic format illustration, not clinic packaging or an approved product label. Compounded creams are not FDA-approved; approval or evidence for one formulation does not transfer to another. Availability and format-specific costs require confirmation.
03 / In-office procedure
Discuss at a consultation
A procedure conversation.
Hormone pellets require an in-office procedure and an individual discussion of suitability, risks and alternatives.
- Setting
- In-person placement; not a video-only procedure.
- Decision
- Procedure risks, formulation and alternatives reviewed.
- Costs
- Procedure and format-specific charges are separate considerations.
Some pellet products are compounded and are not FDA-approved. The monthly testosterone program does not establish that every format or procedure is included. Medication and procedure costs must be confirmed.
Clinical context
The pictured objects do not represent a dose, specific ingredient, available inventory or recommended regimen. Some pellet products are compounded and are not FDA-approved. Testosterone-related monitoring and fertility considerations still apply.
Educational formats—not a bundle, product catalog or guaranteed prescription. Selection and availability are confirmed during an individual evaluation.
Clinical data, made clearA number matters.
A number matters.
Context matters more.
Published research helps explain the clinical conversation. It does not predict an individual result.
Total testosterone
PUBLISHED STUDY / NOT CLINIC RESULTSBefore treatment
227ng/dL
Baseline group median
During treatment
483ng/dL
During the 1-year study period
| Study category | Total testosterone |
|---|---|
| Baseline | 227 ng/dL |
| During 1-year treatment | 483 ng/dL |
Testosterone Trials, Sexual Function study · Men aged 65+ · 234 randomized to testosterone gel.
Baseline versus during-treatment medians, not a month-12 endpoint. Not clinic results, an optimal target or a promised outcome. Read the study ↗
Baseline versus during-treatment medians, not a month-12 endpoint. Not clinic results, an optimal target or a promised outcome. Read the study ↗
The markers. The meaning.
Labs, translated.
A clearer view of the markers that may inform evaluation and follow-up.
AUA diagnostic-support cutoff<300 ng/dL
Total testosterone below this level can support evaluation. It is not a standalone diagnosis or an optimal target. Compatible findings and repeat testing matter.
Clinical marker guideEDUCATION / NO PATIENT VALUES
Total T
Total testosteroneTotal circulating testosterone, including bound and unbound hormone.
Why it matters
Supports evaluation alongside symptoms and repeat morning measurements; one low result is not a diagnosis.
Free T
Free testosteroneUnbound testosterone, measured or calculated with validated methods.
Why it matters
May clarify borderline total testosterone or altered SHBG; not required in every evaluation.
SHBG
Sex hormone-binding globulinProtein that binds testosterone and affects interpretation of total testosterone.
Why it matters
Helps interpret total and calculated free testosterone when binding levels differ.
LH / FSH
Luteinizing hormone / follicle-stimulating hormonePituitary signals involved in testosterone production and sperm development.
Why it matters
When indicated, helps distinguish testicular causes from pituitary or hypothalamic causes.
HbA1c
Hemoglobin A1cAverage blood glucose over approximately two to three months.
Why it matters
Helps assess diabetes risk and monitor glucose management; some blood conditions affect accuracy.
LDL / HDL / TG
Lipid panelCholesterol fractions and triglycerides in blood.
Why it matters
Adds cardiovascular risk context; goals depend on overall risk and clinical history.
DXA
Dual-energy X-ray absorptiometry · body compositionEstimates fat and lean mass; not a blood test.
Why it matters
Shows weight composition beyond the scale; measurement conditions affect comparisons.
IGF-1
Insulin-like growth factor 1 · when indicatedA blood marker reflecting growth-hormone activity, interpreted against age-based ranges.
Why it matters
For suspected growth-hormone disorders or treatment monitoring, not routine wellness screening; a result alone does not diagnose deficiency.
CBC / Hct
Complete blood count / hematocritBlood cell counts and the red-cell proportion of blood.
Why it matters
Testosterone can raise hematocrit; baseline and follow-up testing help assess treatment safety.
PSA
Prostate-specific antigenA prostate-related blood marker; not a cancer diagnosis.
Why it matters
Prostate monitoring depends on age, risk, and shared decision-making; elevated results need clinical interpretation.
Review
Clinical review · not a laboratory testSymptoms, adverse effects, treatment response, and relevant health history.
Why it matters
Connects results with examination, medications, fertility plans, and safety; numbers alone do not determine treatment.
Examples, not a fixed panel. Test selection and timing depend on indication, age, risk, medications, and treatment. Reference ranges vary by assay. DXA and clinical review are not blood tests. AUA guidance ↗
A longer view of men’s healthStrength is a habit.
Strength is a habit.
Care is a process.
Assessment, appropriate treatment and ongoing monitoring form the clinical foundation. Training and daily habits remain part of the wider conversation.
Costs, stated clearlyA consultation.
A consultation.
A separate care decision.
Self-pay. No insurance billing. HSA/FSA eligibility depends on the individual plan. The clinic confirms the complete cost before care begins.
View all pricingIncludes testosterone therapy if prescribed, monthly provider visits, review of follow-up labs and dose adjustments. The $49 first consultation and $50 initial in-office lab panel are separate. Follow-up, additional and repeat lab fees are separate; route-specific and pellet costs require confirmation.
Book NowThe clinical processA clear process.
A clear process.
Care that continues.
01
Establish the clinical picture.
Review medical history, relevant concerns, medications, metabolic health, sleep and reproductive plans.
02
Confirm the findings.
Use appropriate laboratory testing and assess potential causes before deciding whether treatment is indicated.
03
Treat, then reassess.
When TRT is appropriate, establish monitoring and revisit benefits, tolerability and the continuing need for treatment.
Before a conversationClear questions.
Clear questions.
Considered answers.
Context matters. These answers explain the care approach, not an individual treatment recommendation.
Does a low testosterone result mean TRT is needed?
No. Diagnosis requires compatible clinical findings and repeat testing. Reversible causes and other explanations must also be considered.
How does fertility affect the decision?
TRT can suppress sperm production. Current or future fertility plans may change the treatment pathway and warrant specialist input.
Why consider weight and sleep alongside hormones?
These factors can affect the clinical picture. Weight loss can improve obesity-related testosterone reductions in some men, while sleep-disorder assessment may identify a separate care need.
Let’s talk
Start with a conversation.
Houston clinic. Texas telehealth.